Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Tax Provisions (2022 - 2025)

Sunshine Biopharma filings provide 4 years of Tax Provisions readings, the most recent being $408374.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 417.22% to $408374.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $21609.0, a 109.2% increase, with the full-year FY2025 number at $21609.0, up 109.2% from a year prior.
  • Tax Provisions hit $408374.0 in Q4 2025 for Sunshine Biopharma, up from -$137438.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $408374.0 in Q4 2025 to a low of -$343691.0 in Q2 2024.
  • Median Tax Provisions over the past 4 years was $40952.0 (2023), compared with a mean of $31940.1.
  • The widest YoY moves for Tax Provisions: up 425.53% in 2024, down 492.0% in 2024.
  • Sunshine Biopharma's Tax Provisions stood at $233304.0 in 2022, then decreased by 5.59% to $220267.0 in 2023, then tumbled by 158.45% to -$128737.0 in 2024, then soared by 417.22% to $408374.0 in 2025.
  • The last three reported values for Tax Provisions were $408374.0 (Q4 2025), -$137438.0 (Q3 2025), and -$209166.0 (Q2 2025) per Business Quant data.